Our products – closer to health
More and more users worldwide are discovering the product advantages of EmboCept® S DSM 50 µm in DSM-TACE with degradable starch microspheres. EmboCept® S DSM 50 µm is certified for chemoembolization of inoperable liver and lung tumors (DSM-TACE).
PlatiCept®, a lyophilized cisplatin, is ideal for use in interventional oncology. PlatiCept® is approved in Spain and Germany.